What experts predict the pediatric COVID-19 vaccine will do for national vaccination rates – CBC
Just days after Pfizer-BioNTech’s vaccine was approved for those aged 5-11, shots are going into arms
Nov 26, 2021
More than two million Canadian kids aged five to 11 are now eligible to get Pfizer-BioNTech’s COVID-19 pediatric vaccine — and with that comes an opportunity to get closer to reducing transmission of COVID-19 in the country.
But what will the rollout of vaccines for this age group do for national vaccination rates?
As one of the last remaining portions of the population to get vaccinated, kids aged five to 11 will play an important role, health experts say.
“Every additional person that gets vaccinated is a step in the right direction,” said Dr. Tehseen Ladha, a pediatrician and assistant professor of pediatrics at University of Alberta in Edmonton.
